Antibody–Drug Conjugates for Cancer Therapy

by Umbreen Hafeez, Sagun Parakh, Hui K Gan, Andrew M Scott
Published 2020-10-01

Antibody Targeting of Eph Receptors in Cancer

by Peter W. Janes, Mary E. Vail, Hui K. Gan, Andrew M. Scott
Published 2020-05-01

Efficiency of new dose escalation designs in dose-finding phase I trials of molecularly targeted agents.

by Christophe Le Tourneau, Hui K Gan, Albiruni R A Razak, Xavier Paoletti
Published 2012-01-01

Antibody–Drug Conjugates for Cancer Therapy

by Adam C. Parslow, Sagun Parakh, Fook-Thean Lee, Hui K. Gan, Andrew M. Scott
Published 2016-07-01

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma

by Puey-Ling Chia, Sagun Parakh, Ming-Sound Tsao, Nhu-An Pham, Hui K. Gan, Diana Cao, Ingrid J. G. Burvenich, Angela Rigopoulos, Edward B. Reilly, Thomas John, Andrew M. Scott
Published 2020-10-01

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism

by Juliana Gomez, Zammam Areeb, Sarah F. Stuart, Hong P. T. Nguyen, Lucia Paradiso, Ahmad Zulkifli, Sonakshi Madan, Vijay Rajagopal, Magdalene K. Montgomery, Hui K. Gan, Andrew M. Scott, Jordan Jones, Andrew H. Kaye, Andrew P. Morokoff, Rodney B. Luwor
Published 2021-03-01

-Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies

by Fook T. Lee PhD, Ingrid J. G. Burvenich PhD, Nancy Guo MBBS, MSc, Pece Kocovski BSc (Honors), Henri Tochon-Danguy PhD, Uwe Ackermann PhD, Graeme J. O’Keefe PhD, Sylvia Gong PhD, Angela Rigopoulos BSc, MSc, Zhanqi Liu MBBS, PhD, Hui K. Gan MBBS, FRACP, PhD, Andrew M. Scott MBBS, FRACP, MD
Published 2016-06-01